The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Will Be The Estimated Market Size Of The Ovidrel Or Ovitrelle Market By 2030?
Historically, the observed growth stemmed from a rising prevalence of infertility, increased acceptance of fertility treatments, the clinical success of recombinant hCG therapies, an expansion in the number of fertility clinics, and improved diagnostic capabilities for ovulation disorders.
The expansion observed during the forecast period is due to a rising need for ART methods, an global increase in maternal age, more significant financial commitments to fertility healthcare infrastructure, wider insurance options for fertility treatments, and a growth in home-based fertility therapies.
Significant developments in the forecast period involve a greater application of assisted reproductive technologies, an increasing acceptance of pre-filled fertility injections, a rising need for ovulation induction treatments, broader access to fertility care, and a stronger emphasis on patient-convenient drug administration.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20326&type=smp
Which Growth Drivers Are Expected To Support The Ovidrel Or Ovitrelle Market Forward?
The expanding infertility rates are anticipated to fuel the market growth for Ovidrel or Ovitrelle moving forward. Infertility rates denote the proportion of individuals or couples who are unable to conceive after a year of consistent, unprotected sexual activity. Several factors contribute to these rates, including delayed parenthood, lifestyle choices such as obesity and stress, and environmental influences. Ovidrel or Ovitrelle improves infertility treatment by prompting ovulation through recombinant human chorionic gonadotropin (hCG), which facilitates the release of eggs for successful conception. For instance, in August 2025, the Canadian Fertility and Andrology Society, a UK-based national professional organization dedicated to advancing reproductive medicine and science, reported that approximately 8% of couples in Canada with female partners aged 15 to 45 experience infertility. Consequently, the increasing infertility rates are a primary driver for the expansion of the ovidrel or ovitrelle market. The rising occurrence of polycystic ovary syndrome (PCOS) is poised to boost the growth of the ovidrel or ovitrelle market in the coming years. Polycystic ovary syndrome (PCOS) is a hormonal disorder characterized by irregular menstrual cycles, the presence of ovarian cysts, and elevated androgen levels, frequently associated with infertility and metabolic complications. The increasing prevalence of PCOS is driven by factors such as rising obesity rates, changes in lifestyle, and improved awareness and diagnostic methods for the condition. Ovidrel or Ovitrelle assists women with PCOS by stimulating ovulation, thereby triggering the release of mature eggs and enhancing the prospects of conception during fertility treatments. For instance, in June 2023, reports from the World Health Organization (WHO), a Switzerland-based government agency, indicated that polycystic ovary syndrome (PCOS) affects about 8-13% of women of reproductive age, with up to 70% of cases remaining undiagnosed. Therefore, the growing prevalence of polycystic ovary syndrome (PCOS) is a key factor propelling the expansion of the ovidrel or ovitrelle market.
How Is The Ovidrel Or Ovitrelle Market Examined Through Segment Analysis?
The ovidrel or ovitrelle market covered in this report is segmented –
1) By Formulation: Pre-Filled Syringes, Vials
2) By Indication: Assisted Reproductive Technology (ART), Ovulation Induction
3) By Distribution Channel: Hospitals And Clinics, Retail Pharmacies, Online Pharmacies
Which Organizations Are Involved In The Ovidrel Or Ovitrelle Market?
Major companies operating in the ovidrel or ovitrelle market are Merck KGaA, Eli Lilly and Company
Access The Complete Ovidrel Or Ovitrelle Market Report:
https://www.thebusinessresearchcompany.com/report/ovidrel-or-ovitrelle-global-market-report
Which Area Represents The Largest Portion Of The Ovidrel Or Ovitrelle Market?
North America was the largest region in the ovidrel or ovitrelle market in 2025. The regions covered in the ovidrel or ovitrelle market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model